Why the study?
The study aimed to analyze the effectiveness of thoracoscopic ablation of AF and define risk factors for the return of atrial tachyarrhythmias in the long-term follow-up period.
Does thoracoscopic ablation provide long-term freedom from atrial tachyarrhythmias in patients with symptomatic atrial fibrillation?
Does thoracoscopic ablation provide long-term freedom from atrial tachyarrhythmias in patients with symptomatic atrial fibrillation?
Thoracoscopic ablation provides sustained freedom from atrial tachyarrhythmias in the majority of patients at 24 months, with efficacy further improved by a hybrid approach utilizing additional catheter ablation.
May support thoracoscopic ablation for symptomatic AF; hypothesis-generating and leaves open need for randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Стребкова et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: